Cost-IPFfectiveness of antifibrotic treatment: real-life data from a Greek University Hospital
I. Dimeas (Larissa, Greece), S. Sinis (Larissa, Greece), P. Kirgou (Larissa, Greece), L. Ioannis (Larissa, Greece), F. Malli (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), Z. Daniil (Larissa, Greece)
Source: Virtual Congress 2020 – How do different treatment strategies translate into costs



Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Dimeas (Larissa, Greece), S. Sinis (Larissa, Greece), P. Kirgou (Larissa, Greece), L. Ioannis (Larissa, Greece), F. Malli (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), Z. Daniil (Larissa, Greece). Cost-IPFfectiveness of antifibrotic treatment: real-life data from a Greek University Hospital. 4811
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: